User:Mr. Ibrahem/Doripenem

Doripenem, sold under the brand names Doribax among others, is an antibiotic used to treat complicated intra-abdominal infections, urinary tract infections, and pneumonia. It is generally effective against Pseudomonas. It is given by injection into a vein.

Common side effects include infusion site pain, diarrhea, nausea, rash, itchiness, and headache. Other side effects may include anaphylaxis, seizures, and liver problems. While there is no evidence of harm in pregnancy, such use has not been well studied. It is a beta-lactam in the carbapenem class.

Doripenem was approved for medical use in the United States in 2007. While it was approved in Europe in 2008, it was subsequently withdrawn. In the United States 7 days of treatment used to cost about 680 USD. As of 2021; however, it is no longer commercially available.